Picture of Litigation Capital Management logo

LIT — Litigation Capital Management News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro CapValue Trap

Litigation Cap. Mgmt - Update on Commercial Arbitration Loss

RNS Number : 1098C

Litigation Capital Management Ltd

06 October 2025

 

06 October 2025

Litigation Capital Management Limited

("LCM" or the "Company")

Permission to Appeal Commercial Arbitration Loss Rejected

 

Litigation Capital Management Limited (AIM:LIT), an alternative asset manager specialising in dispute financing solutions internationally, announces that its funded party has been unsuccessful in seeking permission to appeal the commercial arbitration loss that was announced on 1 April 2025.  This investment was held at a value of £1.4 million (A$3.0 million) as at 30 June 2025 and that amount will now be written off.

Enquiries

Litigation Capital Management
Patrick Moloney, Chief Executive Officer
David Collins, Chief Financial Officer
Cavendish (Nomad and Broker)Tel: 020 7220 0500
Jonny Franklin-Adams and Isaac Hooper (Corporate Finance)
Tim Redfern (Corporate Broking)
NOTES TO EDITORS Litigation Capital Management (LCM) is an alternative asset manager specialising in disputes financing solutions internationally, which operates two business models. The first is direct investments made from LCM's permanent balance sheet capital and the second is third party fund management. Under those two business models, LCM currently pursues three investment strategies: Single-case funding, Portfolio funding and Acquisitions of claims. LCM generates its revenue from both its direct investments and also performance fees through asset management. Currently headquartered in Sydney, with offices in London and Singapore, LCM listed on AIM in December 2018, trading under the ticker LIT. www.lcmfinance.com   This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END     MSCKZMGGKKLGKZM

Recent news on Litigation Capital Management

See all news